Noel Pauli will present an overview of Adimab's in vivo platform and its capabilities.

William Roach will share how to apply Adimab's diverse tools for novel T cell engagers.

Garrett Rappazzo will present on Adimab's approach to pHLA-targeting therapeutics.

The Adimab team will present on TCEs, developability, peptides, and more as they take the stage and chair sessions.